⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8311602 | 0.70 | — | — | |
| SCHEMBL25987663 | 0.67 | — | — | |
| SCHEMBL40163 | 0.64 | — | — | |
| SCHEMBL25939414 | 0.64 | — | — | |
| SCHEMBL14532197 | 0.64 | — | — | |
| SCHEMBL20038146 | 0.64 | — | — | |
| SCHEMBL24013005 | 0.62 | — | — | |
| SCHEMBL10088069 | 0.62 | — | — | |
| SCHEMBL27489019 | 0.62 | — | — | |
| SCHEMBL5932164 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111620764-A | Selective ether bond breaking method of aryl alkyl ether | 荆楚理工学院 | 2020-09-04 | — | — | CN | claimed |
| CN-108864088-B | The preparation method of novel isoquinoline drug molecule with antibacterial activity | 上海万巷制药有限公司 | 2019-10-11 | — | — | CN | claimed |
| EP-4745134-A1 | PROTEIN ARGINASE METHYLTRANSFERASE-5 INHIBITOR AND MEDICAL USE THEREOF | Jiangsu Yahong Meditech Co., Ltd. (CN) | 2026-05-20 | — | — | EP | disclosed |
| WO-2025137231-A1 | METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2025-06-26 | — | — | WO | disclosed |
| CN-113527305-B | Pharmaceutically acceptable salts of quinoline TGF-beta 1 inhibitors and preparation method thereof | 南京圣和药物研发有限公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-113527306-B | Crystal forms of quinoline TGF-beta 1 inhibitor | 南京圣和药物研发有限公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-120152977-A | Method for purifying compounds | AC免疫有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-115209952-B | Substituted pyrazolopyrimidines and use thereof | 维基分析有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-120077046-A | Triazole-substituted imidazo [1,2-A ] pyrimidines as CGAS inhibitors | 葛兰素史密斯克莱知识产权发展有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-114901280-B | MrgprX2 antagonists and uses thereof | 德米拉公司 | 2025-05-27 | — | — | CN | disclosed |
| CN-119923398-A | Cyclic compounds and methods of use thereof | 薛定谔公司 | 2025-05-02 | — | — | CN | disclosed |
| WO-1996006950-A9 | REDUCTION OF NONSPECIFIC HYBRIDIZATION BY USING NOVEL BASE-PAIRING SCHEMES | — | 1997-05-09 | — | — | WO | disclosed |
| WO-1996006950-A1 | REDUCTION OF NONSPECIFIC HYBRIDIZATION BY USING NOVEL BASE-PAIRING SCHEMES | CHIRON CORPORATION (US) | 1996-03-07 | — | — | WO | disclosed |
| CN-1027067-C | Production of novel 5-fluoronicotinic acids or derivatives thereof | TOYAMA CHEMICAL CO LTD (JP) | 1994-12-21 | — | — | CN | disclosed |
| CN-1019012-B | Process for preparing 1-substituted phenyl-1, 4-dihydro-4-oxo-1, 8-naphthyridine derivatives | TOYAMA CHEMICAL CO LTD (JP) | 1992-11-11 | — | — | CN | disclosed |
| CN-1054975-A | Produce the method for new 5-fluorine nicotinic acid or derivatives thereof or its carboxyl response activity derivant and their salt | TOYAMA CHEMICAL CO LTD (JP) | 1991-10-02 | — | — | CN | disclosed |
| EP-0277520-A2 | Parasiticide on a pyrimidine derivative basis | BAYER AG (DE) | 1988-08-10 | — | — | EP | disclosed |
| EP-0104860-B1 | 1-PHENYL-2(1H,3H)-INDOLONE PSYCHO-THERAPEUTIC AGENTS | PFIZER INC. (US) | 1987-03-18 | — | — | EP | disclosed |
| CN-86100879-A | Novel process for preparing 1-substituted aryl-1, 4-dihydro-4-oxo-1, 8-naphthyridine derivatives and intermediates thereof | — | 1986-12-17 | — | — | CN | disclosed |
| EP-0014454-B1 | PROCESS AND INTERMEDIATES FOR THE PREPARATION OF 2-BENZAZEPINE DERIVATIVES | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1982-09-22 | — | — | EP | disclosed |